71 results on '"Brownley KA"'
Search Results
2. Sympathoadrenergic mechanisms in reduced hemodynamic stress responses after exercise.
- Author
-
Brownley KA, Hinderliter AL, West SG, Girdler SS, Sherwood A, and Light KC
- Abstract
PURPOSE: This study examines the acute effects of moderate aerobic exercise on 1) hemodynamic and sympathetic activity during behavioral stress and 2) beta-adrenergic receptor responsivity in a biracial sample of 24 sedentary adults. METHODS: Before and after exercise, blood pressure (BP), impedance-derived cardiovascular measures, and plasma norepinephrine (NE) and epinephrine (EPI) were assessed during mental arithmetic and active speech tasks, and beta-adrenergic receptor responsivity was assessed using a standard isoproterenol challenge procedure. RESULTS: After exercise, BP, NE, and EPI responses to stress were reduced (0.0001 < P < 0.08), preejection period (PEP) was elongated (P < 0.0001), and beta(1)- and beta(2)-receptor responsivity (P < 0.02) was enhanced. Approximately 65% of the prepost exercise mean arterial pressure response difference could be accounted for by changes in sympathetic factors, with change in NE and PEP being the single best predictors. CONCLUSIONS: Reduced BP responses to stress after acute exercise are strongly linked to a decrease in sympathetic drive, as evidenced by reduced NE responses and elongation of the PEP. Coincident with this overall dampening of the hemodynamic response to stress, increases in cardiac and vascular beta-adrenergic receptor responsivity occur. These findings may have important implications for future translational studies that seek to articulate the mechanisms through which regular aerobic exercise reduces the risks of hypertensive and coronary heart disease. [ABSTRACT FROM AUTHOR]
- Published
- 2003
- Full Text
- View/download PDF
3. Chronic fatigue syndrome: evidence supporting the hypothesis of a behaviorally-activated neuromodulator of fatigue.
- Author
-
Hurwitz BE, Brownley KA, Fletcher MA, and Klimas NG
- Abstract
Chronic Fatigue Syndrome (CFS) is a disorder characterized by a prolonged, debilitating fatigue of unknown etiology. In addition, patients with CFS frequently report enhanced fatigue symptoms following even mild physical exertion, and their tolerance for physical exercise is limited relative to healthy individuals. The physiological mechanisms underlying the excessive fatigue and weakness common to this disorder remain an issue of scientific debate. Collectively, the available data suggest that fatigue in CFS is not due to any neuromuscular dysfunction, per se, but possibly is caused or influenced by some centrally acting mediator that is released during behavioral activities that require physical or mental exertion. In addition to persistent fatigue, there is growing evidence that many CFS patients exhibit alterations in hypothalamic-pituitary-adrenal (HPA) axis and autonomic function, including the inability to maintain the blood pressure response to orthostatic challenge. When an individual engages in mental or physical behavioral activation, .there is a release of numerous centrally acting neuromodulators, some of which have been postulated to influence fatigue. This paper examines the evidence supporting a common pathway through which these centrally-mediated psychological and autonomic abnormalities may be linked. It is hypothesized that as a consequence of behavioral activation there is an abnormality in neuromodulator release or action in individuals with CFS, and that this abnormal neuromodulator activity results in increased fatigue. Furthermore, it is postulated that the CNS initiates a counter-regulatory mechanism to reduce the activity of those systems responsible for the production of the neuromodulator; and that the consequence of this counter-regulatory maneuver is the prevailing dysregulation of the autonomic and HPA axes and other dysfunctional cardiovascular and immunological sequelae. [ABSTRACT FROM AUTHOR]
- Published
- 2000
- Full Text
- View/download PDF
4. Peripheral Biomarkers of Anorexia Nervosa: A Meta-Analysis.
- Author
-
Wu YK, Watson HJ, Del Re AC, Finch JE, Hardin SL, Dumain AS, Brownley KA, and Baker JH
- Subjects
- Humans, Adrenocorticotropic Hormone blood, C-Reactive Protein analysis, C-Reactive Protein metabolism, Hydrocortisone blood, Insulin-Like Growth Factor I metabolism, Insulin-Like Growth Factor I analysis, Leptin blood, Anorexia Nervosa blood, Biomarkers blood, Ghrelin blood
- Abstract
The pathogenesis of anorexia nervosa (AN) has been hypothesized to involve several biological systems. However, reliable biomarkers for AN have yet to be established. This study was aimed to identify statistically significant and clinically meaningful peripheral biomarkers associated with AN. A systematic literature search was conducted to identify studies published in English from inception until 30 June 2022. We conducted two-level random-effects meta-analyses to examine the difference between AN and comparison groups across 52 distinct biomarkers and found that acylated ghrelin, adrenocorticotropic hormone (ACTH), carboxy-terminal collagen crosslinks (CTX), cholesterol, cortisol, des-acyl ghrelin, ghrelin, growth hormone (GH), obestatin, and soluble leptin receptor levels were significantly higher in cases of AN compared with those in non-AN controls. Conversely, C-reactive protein (CRP), CD3 positive, CD8, creatinine, estradiol, follicle-stimulating hormone (FSH), free thyroxine, free triiodothyronine, glucose, insulin, insulin-like growth factor 1 (IGF-1), leptin, luteinizing hormone, lymphocyte, and prolactin levels were significantly lower in AN compared with those in non-AN controls. Our findings indicate that peripheral biomarkers may be linked to the pathophysiology of AN, such as processes of adaptation to starvation. Scientific investigation into peripheral biomarkers may ultimately yield breakthroughs in personalized clinical care for AN.
- Published
- 2024
- Full Text
- View/download PDF
5. Software to manage regulatory workflows for medical device development at academic medical centers: A critical gap.
- Author
-
Rose L, McCaney J, Dave G, Brownley KA, Sheridan D, Shah P, Zapotoczny G, and Espinoza J
- Published
- 2023
- Full Text
- View/download PDF
6. Associations of Stress and Appetite Hormones with Binge Eating in Females with Anorexia Nervosa after Weight Restoration: A Longitudinal Study.
- Author
-
Wu YK, Brownley KA, Bardone-Cone AM, Bulik CM, and Baker JH
- Abstract
Binge eating is a transdiagnostic eating disorder symptom that can occur in patients with anorexia nervosa (AN), persisting after weight restoration, and impeding their recovery. However, little is known about the biological predictors of binge eating after AN weight restoration. The goals of this exploratory study of 73 females with AN were: (1) to examine changes in cortisol, the adrenocorticotropic hormone, norepinephrine, ghrelin (total and active), and leptin levels across the admission, discharge, and 3 months post-discharge from the inpatient AN weight restoration; and (2) to determine whether the target hormones were associated with objective or subjective binge eating (OBE or SBE). The participants completed the self-reported Eating Disorder Examination Questionnaire, Beck Anxiety Inventory, and Beck Depression Inventory-II, and provided fasting whole blood samples for hormone assays. The results showed significant changes in body mass index (BMI), cortisol, total ghrelin, and leptin levels over the three time points. The cortisol levels at admission and discharge were significantly associated with the number of SBE episodes at 3 months post-discharge. Findings suggest the need to replicate and confirm the role of cortisol in predicting the emergence of SBE and uncover the mechanisms underlying SBE and cortisol to prevent SBE and its negative consequences.
- Published
- 2021
- Full Text
- View/download PDF
7. Informed consent: Old and new challenges in the context of the COVID-19 pandemic.
- Author
-
Rothwell E, Brassil D, Barton-Baxter M, Brownley KA, Dickert NW, Ford DE, Kraft SA, McCormick JB, and Wilfond BS
- Abstract
In this paper, we address how the COVID-19 pandemic has impacted informed consent for clinical research through examining experiences within Clinical and Translation Science Award (CTSA) institutions. We begin with a brief overview of informed consent and the challenges that existed prior to COVID-19. Then, we discuss how informed consent processes were modified or changed to address the pandemic, consider what lessons were learned, and present research and policy steps to prepare for future research and public health crises. The experiences and challenges for CTSA institutions offer an important perspective for examining what we have learned about informed consent and determining the next steps for improving the consent process., (© The Association for Clinical and Translational Science 2021.)
- Published
- 2021
- Full Text
- View/download PDF
8. ReGARDD (Regulatory Guidance for Academic Research of Drugs and Devices): The evolution of a collaborative regional CTSA-funded forum and website for regulatory support.
- Author
-
Brownley KA, Rape M, Wood A, Dave G, Henderson C, Severynse-Stevens D, Zmuda M, Earp D, Moody C, Kelly-Pumarol I, Andrews J, Foss KM, Fraser S, Segear E, and Parrish AB
- Abstract
Availability of trained professionals to assist researchers navigating regulatory pathways for new drug and device development is limited within academic institutions. We created ReGARDD (Regulatory Guidance for Academic Research of Drugs and Devices), a regional forum initially involving regulatory professionals from four Clinical and Translational Science Award (CTSA)-funded institutions, to build and capitalize on local expertise and to develop a regulatory guidance website geared toward academic researchers. Since 2015, members organized 15 forums covering topics such as FDA premarket submissions, gene therapy, and intellectual property for devices and therapeutics. Through user feedback, targeted surveys, and ongoing iterative processes, we refined and maintained a shared regulatory website, which reached 6000+ users in 2019. Website updates improved navigation to drug versus device topic areas, provided new educational content and videos to address commonly asked questions, and created a portal for posting upcoming training opportunities. Survey respondents rated the website favorably and endorsed expanding ReGARDD as a centralized resource. ReGARDD strengthened the regional regulatory workforce, increased regulatory efficiency, and promulgated best organizational and operational practices. Broad-scale deployment of the ReGARDD model across the CTSA consortium may facilitate the creation of a network of regional forums and reduce gaps in access to regulatory support., (© The Association for Clinical and Translational Science 2021.)
- Published
- 2021
- Full Text
- View/download PDF
9. Broad-scale informed consent: A survey of the CTSA landscape.
- Author
-
Chandler R, Brady KT, Jerome RN, Eder M, Rothwell E, Brownley KA, and Harris PA
- Abstract
Introduction: Research opportunities associated with the proliferation of the electronic health record (EHR), big data initiatives, and innovative approaches to trial design can present challenges for obtaining and documenting informed consent. Broad-scale informed consent (a term used herein to describe institutional models, rather than the Common Rule's strict regulatory definition for "broad consent") may facilitate the use of existing data and samples and speed the pace of research by minimizing barriers to consent. We explored the use of broad-scale informed consent within the Clinical Translational Science Award (CTSA) Program Network., Methods: We surveyed CTSA Hubs concerning policies, practices, experiences, and needs within three domains of broad-scale informed consent: (1) participant recontact; (2) biospecimens; and (3) clinical data sharing., Results: Of 61 CTSA Hubs surveyed, 37 (61%) indicated ongoing work related to at least 1 domain of broad-scale informed consent; 18 Hubs (30%) reported work in all 3 domains. The EHR predominated as the implementation system across all three domains. Research and IT leadership and the Institutional Review Board were most commonly endorsed as institutional drivers, while systems/technical issues and impact on clinical workflow were the most commonly reported barriers., Conclusions: While survey results indicate considerable variability in the implementation of broad-scale informed consent across the CTSA consortium, it is clear that all CTSA Hubs are actively considering policy and process related to these concepts. Next steps cluster within three areas: training and workforce development, streamlined policies and templates, and implementation strategies that facilitate integration into clinical workflow., (© The Association for Clinical and Translational Science 2019.)
- Published
- 2019
- Full Text
- View/download PDF
10. Stress-induced eating in women with binge-eating disorder and obesity.
- Author
-
Klatzkin RR, Gaffney S, Cyrus K, Bigus E, and Brownley KA
- Subjects
- Adolescent, Adult, Affect, Anxiety psychology, Body Mass Index, Female, Humans, Hunger, Middle Aged, Young Adult, Binge-Eating Disorder psychology, Eating psychology, Feeding Behavior psychology, Obesity psychology, Stress, Psychological psychology
- Abstract
The purpose of the current study was to investigate stress-induced eating in women with binge-eating disorder (BED) and obesity. Three groups of women [obese with BED (n=9); obese non-BED (n=11); and normal weight (NW) non-BED (n=12)], rated their levels of hunger and psychological distress before and after completing the Trier Social Stress Test, followed by food anticipation and then consumption of their preferred snack food. We differentiated between the motivational and hedonic components of eating by measuring the amount of food participants poured into a serving bowl compared to the amount consumed. Stress did not affect poured and consumed calories differently between groups. Across all subjects, calories poured and consumed were positively correlated with post-stress hunger, but calories poured was positively correlated with post-stress anxiety and negative affect. These results indicate that stress-related psychological factors may be more strongly associated with the motivational drive to eat (i.e. amount poured) rather than the hedonic aspects of eating (i.e. amount consumed) for women in general. Exploratory correlation analyses per subgroup suggest that post-stress hunger was positively associated with calories poured and consumed in both non-BED groups. In the obese BED group, calories consumed was negatively associated with dietary restraint and, although not significantly, positively associated with stress-induced changes in anxiety.These findings suggest that stress-induced snacking in obese BED women may be influenced by psychological factors more so than homeostatic hunger mechanisms. After controlling for dietary restraint and negative affect, the NW non-BED women ate a greater percentage of the food they poured than both obese groups, suggesting that obesity may be associated with a heightened motivational drive to eat coupled with a reduction in hedonic pleasure from eating post-stress. Further studies that incorporate novel approaches to measuring the motivational versus hedonic aspects of stress-induced eating may expose nuanced eating behaviors that differentiate BED and obesity. If confirmed, our findings would support prevention and treatment strategies that target subsets of women based on obesity and BED status., (Copyright © 2016 Elsevier B.V. All rights reserved.)
- Published
- 2018
- Full Text
- View/download PDF
11. Sweet taste preference in binge-eating disorder: A preliminary investigation.
- Author
-
Goodman EL, Breithaupt L, Watson HJ, Peat CM, Baker JH, Bulik CM, and Brownley KA
- Subjects
- Adolescent, Adult, Binge-Eating Disorder epidemiology, Craving, Diet Surveys, Energy Intake, Female, Glucose Tolerance Test, Humans, Male, Middle Aged, Young Adult, Binge-Eating Disorder psychology, Food Preferences, Sweetening Agents, Taste
- Abstract
Research suggests that individuals with high liking for sweets are at increased risk for binge eating, which has been minimally investigated in individuals with binge-eating disorder (BED). Forty-one adults (85% female, 83% white) with binge eating concerns completed a sweet taste test and measures of eating disorder behaviors and food cravings. A subset of participants with BED completed an oral glucose tolerance test (OGTT; N=21) and a 24-hour dietary recall (N=26). Regression models were used to compare highest sweet preferers (HSP [N=18]) to other sweet preferers (OSP [N=23]) and were used to assess associations between sweet taste preference and outcome variables. Effect sizes (ηp
2 ) for differences between HSP and OSP ranged from small (≤0.01) to large (≥0.24); group differences were statistically nonsignificant except for 24-hour caloric intake (ηp2 =0.16, p=0.04), protein intake (ηp2 =0.16, p=0.04), and insulin sensitivity index (ηp2 =0.24, p=0.04), which were higher in HSP, and postprandial insulin, which was smaller in HSP (ηp2 =0.27, p=0.03). Continuous analyses replicated postprandial insulin response. Compared with OSP, HSP reported numerically higher binge-eating frequency (ηp2 =0.04), over-eating frequency (ηp2 =0.06), and carbohydrate intake (ηp2 =0.14), and they exhibited numerically smaller postprandial glucose AUC (ηp2 =0.16). Sweet taste preference may have implications for glucose regulation, binge-eating frequency, and nutrient intake in BED., (Copyright © 2017 Elsevier Ltd. All rights reserved.)- Published
- 2018
- Full Text
- View/download PDF
12. Comparative Effectiveness of Treatments for Binge-Eating Disorder: Systematic Review and Network Meta-Analysis.
- Author
-
Peat CM, Berkman ND, Lohr KN, Brownley KA, Bann CM, Cullen K, Quattlebaum MJ, and Bulik CM
- Subjects
- Antidepressive Agents, Second-Generation therapeutic use, Binge-Eating Disorder drug therapy, Cognitive Behavioral Therapy, Humans, Lisdexamfetamine Dimesylate therapeutic use, Randomized Controlled Trials as Topic, Treatment Outcome, Binge-Eating Disorder therapy
- Abstract
Psychological and pharmacological interventions for binge-eating disorder have previously demonstrated efficacy (compared with placebo or waitlist control); thus, we aimed to expand that literature with a review of comparative effectiveness. We searched MEDLINE,® EMBASE,® Cochrane Library, Academic OneFile, CINAHL® for binge-eating disorder treatment articles and selected studies using predetermined inclusion and exclusion criteria. Data were sufficient for network meta-analysis comparing two pharmacological interventions; psychological interventions were analysed qualitatively. In all, 28 treatment comparisons were included in this review: one pharmacological comparison (second-generation antidepressants versus lisdexamfetamine) and 26 psychological comparisons. Only three statistically significant differences emerged: lisdexamfetamine was better at increasing binge abstinence than second-generation antidepressants; therapist-led cognitive behavioural therapy was better at reducing binge-eating frequency than behavioural weight loss, but behavioural weight loss was better at reducing weight. The majority of other treatment comparisons revealed few significant differences between groups. Thus, patients and clinicians can choose from several effective treatment options. Copyright © 2017 John Wiley & Sons, Ltd and Eating Disorders Association., (Copyright © 2017 John Wiley & Sons, Ltd and Eating Disorders Association.)
- Published
- 2017
- Full Text
- View/download PDF
13. A Comparison of Personality, Life Events, Comorbidity, and Health in Monozygotic Twins Discordant for Anorexia Nervosa.
- Author
-
Thornton LM, Trace SE, Brownley KA, Ålgars M, Mazzeo SE, Bergin JE, Maxwell M, Lichtenstein P, Pedersen NL, and Bulik CM
- Subjects
- Adult, Female, Humans, Middle Aged, Anorexia Nervosa genetics, Anorexia Nervosa physiopathology, Anorexia Nervosa psychology, Personality genetics, Personality physiology, Twins, Monozygotic genetics, Twins, Monozygotic psychology
- Abstract
Genetic and environmental factors contribute to the etiology of anorexia nervosa (AN). The co-twin control design is one of the most powerful methods available to evaluate environmental factors that could contribute to differences between monozygotic (MZ) twins who are discordant for AN. Using available data from a unique and rare sample of 22 Swedish female MZ pairs discordant for AN, we compared personality, life events, comorbidity, and health factors. Twins with AN had significantly higher perfectionism scores than unaffected co-twins and reported younger ages at first diet than unaffected co-twins who had dieted. Consistent with previous literature, more twins with AN reported gastrointestinal problems than unaffected co-twins. Although not significant due to low statistical power, more unaffected co-twins reported experiencing emotional neglect than twins with AN. Early dieting may be a harbinger of the development of AN or an early symptom. Higher perfectionism may represent a risk factor, sequela, or both. Sibling perception of neglect is noteworthy given the impact of an ill child with AN on family function and wellbeing. The health and wellbeing of siblings should be addressed clinically when one child in the family suffers from AN.
- Published
- 2017
- Full Text
- View/download PDF
14. Preventing and De-escalating Aggressive Behavior Among Adult Psychiatric Patients: A Systematic Review of the Evidence.
- Author
-
Gaynes BN, Brown CL, Lux LJ, Brownley KA, Van Dorn RA, Edlund MJ, Coker-Schwimmer E, Weber RP, Sheitman B, Zarzar T, Viswanathan M, and Lohr KN
- Subjects
- Humans, Aggression, Hospitals, Psychiatric, Inpatients, Violence prevention & control
- Abstract
Objective: The project goal was to compare the effectiveness of strategies to prevent and de-escalate aggressive behaviors among psychiatric patients in acute care settings, including interventions for reducing use of seclusion and restraint., Methods: Relevant databases were systematically reviewed for comparative studies of violence prevention and de-escalation strategies involving adult psychiatric patients in acute care settings. Studies (trials and cohort studies) were required to report on aggression or seclusion or restraint outcomes. Both risk of bias, an indicator of quality of individual studies, and strength of evidence (SOE) for each outcome were independently assessed by two study personnel., Results: Seventeen primary studies met inclusion criteria. Evidence was limited for benefits and harms; information about characteristics that might modify the interventions' effectiveness, such as race or ethnicity, was especially limited. All but one study had a medium or high risk of bias and thus presented worrisome limitations. For prevention, risk assessment reduced both aggression and use of seclusion and restraint (low SOE), and multimodal interventions reduced the use of seclusion and restraint (low SOE). SOE for all other interventions, whether aimed at preventing or de-escalating aggression, and for modifying characteristics was insufficient., Conclusions: Available evidence about strategies for preventing and de-escalating aggressive behavior among psychiatric patients is very limited. Two preventive strategies, risk assessment and multimodal interventions consistent with the Six Core Strategies principles, may effectively lower aggressive behavior and use of seclusion and restraint, but more research is needed on how best to prevent and de-escalate aggressive behavior in acute care settings.
- Published
- 2017
- Full Text
- View/download PDF
15. Reproductive and Appetite Hormones and Bulimic Symptoms during Midlife.
- Author
-
Baker JH, Peterson CM, Thornton LM, Brownley KA, Bulik CM, Girdler SS, Marcus MD, and Bromberger JT
- Subjects
- Adult, Appetite physiology, Female, Humans, Middle Aged, Reproduction physiology, Risk Factors, Self Report, Bulimia Nervosa physiopathology, Hormones metabolism, Perimenopause physiology, Premenopause physiology
- Abstract
Eating disorders and related symptoms occur during midlife; however, little is known about their aetiology. It has been hypothesised that perimenopause represents a window of vulnerability for the development or exacerbation of eating disorder symptomatology because, like puberty, perimenopause is a period of reproductive hormone change. We compared symptoms of bulimia nervosa (bulimic symptomatology) assessed via mean scores on a self-report questionnaire in premenopausal and perimenopausal women. We also examined the association between hormone concentrations (reproductive/appetite) and bulimic symptomatology. No mean differences in bulimic symptomatology were observed between premenopause and perimenopause. However, there was a significant positive association between leptin and binge eating. Although no significant associations between reproductive hormones and bulimic symptomatology were observed, additional research is needed to provide definitive information. It is essential to learn more about the aetiology of eating disorders and related symptomatology across the lifespan in order to develop age-relevant treatment and prevention programs. Copyright © 2017 John Wiley & Sons, Ltd and Eating Disorders Association., (Copyright © 2017 John Wiley & Sons, Ltd and Eating Disorders Association.)
- Published
- 2017
- Full Text
- View/download PDF
16. A Double-Blind, Randomized Pilot Trial of Chromium Picolinate for Overweight Individuals with Binge-Eating Disorder: Effects on Glucose Regulation.
- Author
-
Sala M, Breithaupt L, Bulik CM, Hamer RM, La Via MC, and Brownley KA
- Subjects
- Adult, Binge-Eating Disorder blood, Binge-Eating Disorder complications, Blood Glucose analysis, Blood Glucose drug effects, Dose-Response Relationship, Drug, Double-Blind Method, Female, Glucose Tolerance Test, Humans, Hypoglycemic Agents administration & dosage, Insulin blood, Insulin Resistance, Male, Middle Aged, Overweight blood, Overweight psychology, Pilot Projects, Time Factors, Binge-Eating Disorder drug therapy, Hypoglycemic Agents therapeutic use, Overweight drug therapy, Picolinic Acids administration & dosage, Picolinic Acids therapeutic use
- Abstract
Purpose: Chromium treatment has been shown to improve glucose regulation in some populations. The purpose of this study was to evaluate whether chromium picolinate (CrPic) supplementation improves glucose regulation in overweight individuals with binge-eating disorder (BED)., Methods: In this double-blinded randomized pilot trial, participants (N = 24) were randomized to high (HIGH, 1000 mcg/day, n = 8) or moderate (MOD, 600 mcg/day, n = 9) dose of CrPic or placebo (PL, n = 7) for 6 months. Participants completed an oral glucose tolerance test (OGTT) at baseline, 3 months, and 6 months. Fixed effects models were used to estimate mean change in glucose area under the curve (AUC), insulin
AUC , and insulin sensitivity index (ISI)., Results: Results revealed a significant group and time interaction (p < 0.04) for glucoseAUC , with glucoseAUC increasing significantly in the PL group (p < 0.02) but decreasing significantly in the MOD group (p < 0.03) at 6 months. InsulinAUC increased significantly over time (main effect, p < 0.02), whereas ISI decreased significantly over time (main effect, p < 0.03)., Conclusion: As anticipated, a moderate dose of CrPic was associated with improved glycemic control, whereas PL was associated with decreased glycemic control. It was unexpected that the improved glycemic control seen in the MOD dose group was not seen in the HIGH dose group. However, although participants randomized to the HIGH dose group did not have improved glycemic control, they had better glycemic control than participants randomized to the PL group. These findings support the need for larger trials.- Published
- 2017
- Full Text
- View/download PDF
17. Binge-Eating Disorder in Adults.
- Author
-
Brownley KA, Berkman ND, Peat CM, Lohr KN, and Bulik CM
- Subjects
- Adult, Humans, Binge-Eating Disorder, Surveys and Questionnaires
- Published
- 2017
- Full Text
- View/download PDF
18. Body image, aging, and identity in women over 50: The Gender and Body Image (GABI) study.
- Author
-
Hofmeier SM, Runfola CD, Sala M, Gagne DA, Brownley KA, and Bulik CM
- Subjects
- Female, Humans, Middle Aged, Qualitative Research, Women's Health, Aging psychology, Attitude to Health, Body Image psychology, Gender Identity
- Abstract
We conducted a qualitative study of 1,849 women over age 50 to capture the thoughts, feelings, and attitudes that women at middle age have about their bodies and the experience of aging. Via an open-ended question online survey, four primary themes emerged: (a) the physical and psychological experience of aging; (b) the injustices, inequities, and challenges of aging; (c) the importance of self-care; and (d) a plea for recognition of the need to maintain a contributory role in society. Results highlight the complexities of women's psychological and physical aspects of aging and point toward important topics worthy of further study in this growing population.
- Published
- 2017
- Full Text
- View/download PDF
19. Binge-Eating Disorder in Adults: A Systematic Review and Meta-analysis.
- Author
-
Brownley KA, Berkman ND, Peat CM, Lohr KN, Cullen KE, Bann CM, and Bulik CM
- Subjects
- Adult, Anti-Obesity Agents adverse effects, Anti-Obesity Agents therapeutic use, Antidepressive Agents, Second-Generation adverse effects, Antidepressive Agents, Second-Generation therapeutic use, Binge-Eating Disorder drug therapy, Binge-Eating Disorder psychology, Central Nervous System Stimulants adverse effects, Central Nervous System Stimulants therapeutic use, Cognitive Behavioral Therapy, Fructose adverse effects, Fructose analogs & derivatives, Fructose therapeutic use, Humans, Lisdexamfetamine Dimesylate adverse effects, Lisdexamfetamine Dimesylate therapeutic use, Topiramate, Binge-Eating Disorder therapy
- Abstract
Background: The best treatment options for binge-eating disorder are unclear., Purpose: To summarize evidence about the benefits and harms of psychological and pharmacologic therapies for adults with binge-eating disorder., Data Sources: English-language publications in EMBASE, the Cochrane Library, Academic OneFile, CINAHL, and ClinicalTrials.gov through 18 November 2015, and in MEDLINE through 12 May 2016., Study Selection: 9 waitlist-controlled psychological trials and 25 placebo-controlled trials that evaluated pharmacologic (n = 19) or combination (n = 6) treatment. All were randomized trials with low or medium risk of bias., Data Extraction: 2 reviewers independently extracted trial data, assessed risk of bias, and graded strength of evidence., Data Synthesis: Therapist-led cognitive behavioral therapy, lisdexamfetamine, and second-generation antidepressants (SGAs) decreased binge-eating frequency and increased binge-eating abstinence (relative risk, 4.95 [95% CI, 3.06 to 8.00], 2.61 [CI, 2.04 to 3.33], and 1.67 [CI, 1.24 to 2.26], respectively). Lisdexamfetamine (mean difference [MD], -6.50 [CI, -8.82 to -4.18]) and SGAs (MD, -3.84 [CI, -6.55 to -1.13]) reduced binge-eating-related obsessions and compulsions, and SGAs reduced symptoms of depression (MD, -1.97 [CI, -3.67 to -0.28]). Headache, gastrointestinal upset, sleep disturbance, and sympathetic nervous system arousal occurred more frequently with lisdexamfetamine than placebo (relative risk range, 1.63 to 4.28). Other forms of cognitive behavioral therapy and topiramate also increased abstinence and reduced binge-eating frequency and related psychopathology. Topiramate reduced weight and increased sympathetic nervous system arousal, and lisdexamfetamine reduced weight and appetite., Limitations: Most study participants were overweight or obese white women aged 20 to 40 years. Many treatments were examined only in single studies. Outcomes were measured inconsistently across trials and rarely assessed beyond end of treatment., Conclusion: Cognitive behavioral therapy, lisdexamfetamine, SGAs, and topiramate reduced binge eating and related psychopathology, and lisdexamfetamine and topiramate reduced weight in adults with binge-eating disorder., Primary Funding Source: Agency for Healthcare Research and Quality.
- Published
- 2016
- Full Text
- View/download PDF
20. Active ghrelin and the postpartum.
- Author
-
Baker JH, Pedersen C, Leserman J, and Brownley KA
- Subjects
- Adolescent, Adult, Anxiety psychology, Anxiety urine, Bottle Feeding, Depression, Postpartum psychology, Depression, Postpartum urine, Female, Ghrelin urine, Humans, Lactation urine, Postpartum Period urine, Pregnancy, Young Adult, Anxiety diagnosis, Breast Feeding, Depression, Postpartum diagnosis, Ghrelin metabolism, Lactation metabolism, Postpartum Period metabolism
- Abstract
Postpartum depression (PPD) occurs in 10-15 % of women. The appetite hormone ghrelin, which fluctuates during pregnancy, is associated with depression in nonpregnant samples. Here, we examine the association between PPD and active ghrelin from pregnancy to postpartum. We additionally examine whether ghrelin changes from pregnancy to postpartum and differs between breastfeeding and non-breastfeeding women. Sixty women who participated in a survey examining PPD and had information in regard to ghrelin concentrations were included in the study. The Edinburgh Postnatal Depression Scale was used to assess symptoms of PPD. Raw ghrelin levels and ghrelin levels adjusted for creatinine were included as outcomes. Women screening positive for PPD at 12 weeks postpartum had higher pregnancy ghrelin concentrations. Ghrelin concentrations significantly decreased from pregnancy to 6 weeks postpartum and this change differed based on pregnancy depression status. Finally, ghrelin levels were lower in women who breastfed compared with women who were bottle-feeding. No significant findings remained once ghrelin levels were adjusted for creatinine. Although results do not suggest an association between PPD and ghrelin after adjusting for creatinine, future research should continue to explore this possibility extending further across the postpartum period with larger sample sizes.
- Published
- 2016
- Full Text
- View/download PDF
21. Psychological treatments for adults with posttraumatic stress disorder: A systematic review and meta-analysis.
- Author
-
Cusack K, Jonas DE, Forneris CA, Wines C, Sonis J, Middleton JC, Feltner C, Brownley KA, Olmsted KR, Greenblatt A, Weil A, and Gaynes BN
- Subjects
- Cognitive Behavioral Therapy methods, Eye Movement Desensitization Reprocessing methods, Humans, Implosive Therapy methods, Cognitive Behavioral Therapy statistics & numerical data, Eye Movement Desensitization Reprocessing statistics & numerical data, Implosive Therapy statistics & numerical data, Outcome Assessment, Health Care statistics & numerical data, Stress Disorders, Post-Traumatic therapy
- Abstract
Numerous guidelines have been developed over the past decade regarding treatments for Posttraumatic stress disorder (PTSD). However, given differences in guideline recommendations, some uncertainty exists regarding the selection of effective PTSD therapies. The current manuscript assessed the efficacy, comparative effectiveness, and adverse effects of psychological treatments for adults with PTSD. We searched MEDLINE, Cochrane Library, PILOTS, Embase, CINAHL, PsycINFO, and the Web of Science. Two reviewers independently selected trials. Two reviewers assessed risk of bias and graded strength of evidence (SOE). We included 64 trials; patients generally had severe PTSD. Evidence supports efficacy of exposure therapy (high SOE) including the manualized version Prolonged Exposure (PE); cognitive therapy (CT), cognitive processing therapy (CPT), cognitive behavioral therapy (CBT)-mixed therapies (moderate SOE); eye movement desensitization and reprocessing (EMDR) and narrative exposure therapy (low-moderate SOE). Effect sizes for reducing PTSD symptoms were large (e.g., Cohen's d ~-1.0 or more compared with controls). Numbers needed to treat (NNTs) were <4 to achieve loss of PTSD diagnosis for exposure therapy, CPT, CT, CBT-mixed, and EMDR. Several psychological treatments are effective for adults with PTSD. Head-to-head evidence was insufficient to determine these treatments' comparative effectiveness, and data regarding adverse events was absent from most studies., (Published by Elsevier Ltd.)
- Published
- 2016
- Full Text
- View/download PDF
22. Dietary chromium supplementation for targeted treatment of diabetes patients with comorbid depression and binge eating.
- Author
-
Brownley KA, Boettiger CA, Young L, and Cefalu WT
- Subjects
- Diabetes Mellitus, Type 2 complications, Diabetes Mellitus, Type 2 physiopathology, Humans, Bulimia, Chromium administration & dosage, Depression complications, Diabetes Mellitus, Type 2 drug therapy, Dietary Supplements
- Abstract
Dietary chromium supplementation for the treatment of diabetes remains controversial. The prevailing view that chromium supplementation for glucose regulation is unjustified has been based upon prior studies showing mixed, modest-sized effects in patients with type 2 diabetes (T2DM). Based on chromium's potential to improve insulin, dopamine, and serotonin function, we hypothesize that chromium has a greater glucoregulatory effect in individuals who have concurrent disturbances in dopamine and serotonin function--that is, complex patients with comorbid diabetes, depression, and binge eating. We propose, as suggested by the collective data to date, the need to go beyond the "one size fits all" approach to chromium supplementation and put forth a series of experiments designed to link physiological and neurobehavioral processes in the chromium response phenotype., (Copyright © 2015 Elsevier Ltd. All rights reserved.)
- Published
- 2015
- Full Text
- View/download PDF
23. Binge eating disorder and obesity: preliminary evidence for distinct cardiovascular and psychological phenotypes.
- Author
-
Klatzkin RR, Gaffney S, Cyrus K, Bigus E, and Brownley KA
- Subjects
- Adult, Anxiety physiopathology, Binge-Eating Disorder complications, Blood Pressure physiology, Body Mass Index, Contraceptives, Oral, Hormonal therapeutic use, Depression physiopathology, Feeding Behavior, Female, Heart Rate physiology, Humans, Hunger physiology, Middle Aged, Neuropsychological Tests, Obesity complications, Psychiatric Status Rating Scales, Self Report, Stress, Psychological physiopathology, Surveys and Questionnaires, Young Adult, Binge-Eating Disorder physiopathology, Binge-Eating Disorder psychology, Obesity physiopathology, Obesity psychology
- Abstract
This study investigated cardiovascular functioning, mood, and eating-related psychological factors at rest and in response to mental stress in three groups of women: 1) Obese women with binge eating disorder (BED; n=9); 2) obese non-BED women (n=15); and 3) normal weight (NW) non-BED women (n=15). Compared to both obese and NW non-BED women, obese women with BED showed heightened overall blood pressure and reported greater depression symptoms, perceived stress, and eating-related psychopathology. Additionally, obese women with BED reported greater overall negative affect and state anxiety compared to obese non-BED women. The heart rate response to stress was blunted in the obese BED group compared to the other groups, but this effect was no longer significant after controlling for baseline differences in depression. Correlational analyses revealed a positive association between stress-induced changes in hunger and cardiovascular measures only in obese women with BED. Longitudinal studies are needed to determine if stress dysregulation and stress-induced increases in hunger contribute to the onset and/or maintenance of BED. In particular, studies utilizing an additional NW BED control group are warranted in order to further examine the impact of BED above and beyond the impact of obesity on psychophysiological functioning and to inform the growing literature regarding stress-related factors that distinguish the BED and obesity phenotypes., (Copyright © 2015 Elsevier Inc. All rights reserved.)
- Published
- 2015
- Full Text
- View/download PDF
24. Pharmacological approaches to the management of binge eating disorder.
- Author
-
Brownley KA, Peat CM, La Via M, and Bulik CM
- Subjects
- Adolescent, Adult, Antidepressive Agents pharmacology, Antidepressive Agents therapeutic use, Binge-Eating Disorder etiology, Binge-Eating Disorder physiopathology, Female, Humans, Male, Psychotropic Drugs pharmacology, Psychotropic Drugs therapeutic use, Binge-Eating Disorder drug therapy
- Abstract
In the USA, binge eating disorder (BED) is the most common eating disorder, with a lifetime prevalence of ~3.5 % in adult women, 2.0 % in adult men, and 1.6 % in adolescents. BED is characterized by frequent episodes of binge eating that are accompanied by a sense of loss of control over eating and result in marked psychological distress. BED is highly co-morbid with obesity and with depression and other psychiatric conditions, and it is associated with substantial role impairment. Currently, there are no US FDA-approved pharmacological treatments for BED. Animal and human studies implicate underlying dysregulation in dopamine, opioid, acetylcholine, and serotonin neurocircuitry within brain reward regions in the pathogenesis and maintenance of BED. To date, the efficacy of various agents that target these and other neurotransmitter systems involved in motivated feeding behavior, mood regulation, and impulse control have been investigated in the treatment of BED. Several antidepressant and anticonvulsant agents have demonstrated efficacy in reducing binge eating frequency, but only in limited cases have these effects resulted in patients achieving abstinence, which is the primary goal of treatment; they also range from less (fluvoxamine) to more (topiramate) effective in achieving weight loss that is both clinically meaningful and significantly greater than placebo. Collectively, the literature on pharmacological treatment approaches to BED is limited in that very few agents have been studied in multiple, confirmatory trials with adequate follow up, and almost none have been evaluated in large patient samples that are diverse with respect to age, sex, and ethnicity. In addition, prior trials have not adequately addressed, through study design, the high placebo response commonly observed in this patient population. Several novel agents are in various phases of testing, and recent animal studies focusing on glutamate-signaling circuits linking the amygdala to the lateral hypothalamus offer new avenues for exploration and potential therapeutic development. Studies of newly FDA-approved medications for long-term obesity treatment and further explorations of dietary supplements and neutraceuticals with appetite- and mood-altering properties may also be worthwhile.
- Published
- 2015
- Full Text
- View/download PDF
25. The expression of cytokines and chemokines in the blood of patients with severe weight loss from anorexia nervosa: an exploratory study.
- Author
-
Pisetsky DS, Trace SE, Brownley KA, Hamer RM, Zucker NL, Roux-Lombard P, Dayer JM, and Bulik CM
- Subjects
- Adolescent, Adult, Body Composition, Chemokine CCL5 biosynthesis, Enzyme-Linked Immunosorbent Assay, Exercise, Female, Humans, Middle Aged, Pilot Projects, Psychiatric Status Rating Scales, Surveys and Questionnaires, Weight Loss, Young Adult, Anorexia Nervosa blood, Chemokine CCL5 blood, Depression complications, Interleukin-6 blood
- Abstract
Anorexia nervosa (AN) is a serious, potentially life-threatening disorder characterized by severe weight loss, dysregulated eating, and often excessive exercise. While psychiatric illnesses such as depression are associated with increased levels of pro-inflammatory mediators, evidence for such disturbances in patients with AN has been less clear. In an exploratory study of possible disturbances in immune responses in AN, we assayed a panel of cytokines and chemokines in the blood of patients undergoing inpatient treatment, testing the hypothesis that metabolic disturbances in this disease would lead to a pattern of immune disturbances distinct from that of other psychiatric diseases. For this purpose, we evaluated patients by the Beck Depression Inventory-II (BDI-II) and the Eating Disorders Examination-Questionnaire and assessed cytokines and chemokines by enzyme-linked immunosorbent assays. Patients reported a moderate level of depression (mean BDI-II = 22.6) but exhibited few immunologic abnormalities of the kind associated with major depressive disorder [e.g., increased interleukin (IL)-6]; RANTES showed the most frequent elevations and was increased in 4 of the patients studied. Together, these findings suggest that features of AN such as loss of adipose tissue and excessive exercise may attenuate cytokine production and thus modulate the experience of illness that impacts on core features of disease., (Copyright © 2014 Elsevier Ltd. All rights reserved.)
- Published
- 2014
- Full Text
- View/download PDF
26. Chromium supplementation for menstrual cycle-related mood symptoms.
- Author
-
Brownley KA, Girdler SS, Stout AL, and McLeod MN
- Subjects
- Adult, Antidepressive Agents pharmacology, Antidepressive Agents therapeutic use, Chromium pharmacology, Double-Blind Method, Female, Health, Humans, Menstrual Cycle psychology, Middle Aged, Patient Satisfaction, Premenstrual Syndrome psychology, Sertraline pharmacology, Sertraline therapeutic use, Single-Blind Method, Trace Elements pharmacology, Treatment Outcome, Young Adult, Affect drug effects, Chromium therapeutic use, Dietary Supplements, Menstrual Cycle drug effects, Premenstrual Syndrome drug therapy, Trace Elements therapeutic use
- Abstract
Background: Premenstrual dysphoric disorder (PMDD) afflicts ~7% of reproductive-age women resulting in impaired relationships, diminished overall quality of life, and disability-adjusted life years lost on par with other major psychiatric disorders. Response to pharmacological treatment is inadequate in ~50% of women with PMDD., Objective: The goal of the present study is to evaluate the effects of a novel approach-short-term chromium supplementation-on menstrual cycle-related mood and physical symptoms., Methods: Five women were studied under single-blind conditions in a private clinical setting (2 of them were referred specifically for treatment-resistant menstrual-related symptoms); 6 women completed a double-blind crossover study of chromium plus placebo versus chromium plus sertraline in a university clinical research setting. Treatments were administered from mid-cycle to onset of menses in 1-month intervals. Symptom ratings were obtained by self-report, using daily symptom checklists, and by clinical assessment, using the Hamilton Psychiatric Rating Scale for Depression (HAM-D) and the Clinical Global Impressions (CGI) scale., Results: Overall, chromium treatment was associated with reduced mood symptoms and improved overall health satisfaction in most participants. In some cases, chromium alone was associated with marked clinical improvement; in others, chromium plus an antidepressant resulted in greater improvement than either chromium alone or an antidepressant alone., Conclusion: These preliminary observations suggest that chromium may be a useful monotherapy or adjunctive therapy for women suffering from significant menstrual cycle-related symptoms. Larger, controlled studies are needed to evaluate the efficacy of chromium treatment in this patient population.
- Published
- 2013
- Full Text
- View/download PDF
27. Assessment of gene expression in peripheral blood using RNAseq before and after weight restoration in anorexia nervosa.
- Author
-
Kim Y, Trace SE, Crowley JJ, Brownley KA, Hamer RM, Pisetsky DS, Sullivan PF, and Bulik CM
- Subjects
- Absorptiometry, Photon, Adult, Body Composition, Female, Humans, Young Adult, Anorexia Nervosa blood, Anorexia Nervosa physiopathology, Anorexia Nervosa therapy, Gene Expression Regulation physiology, Sequence Analysis, RNA, Weight Gain physiology
- Abstract
We examined gene expression in the blood of six females with anorexia nervosa (AN) before and after weight restoration using RNAseq. AN cases (aged 19-39) completed clinical assessments and had blood drawn for RNA at hospital admission (T1,<~75% ideal body weight, IBW) and again at discharge (T2,≥ ~ 85% IBW). To examine the relationship between weight restoration and differential gene expression, normalized gene expression levels were analyzed using a paired design. We found 564 genes whose expression was nominally significantly different following weight restoration (p<0.01, 231 increased and 333 decreased). With a more stringent significance threshold (false discovery rate q<0.05), 67 genes met criteria for differential expression. Of the top 20 genes, CYP11A1, C16orf11, LINC00235, and CPA3 were down-regulated more than two-fold after weight restoration while multiple olfactory receptor genes (OR52J3, OR51L1, OR51A4, and OR51A2) were up-regulated more than two-fold after weight restoration. Pathway analysis revealed up-regulation of two broad pathways with largely overlapping genes, one related to protein secretion and signaling and the other associated with defense response to bacterial regulation. Although results are preliminary secondary to a small sample size, these data provide initial evidence of transcriptional alterations during weight restoration in AN., (© 2013 Elsevier Ireland Ltd. All rights reserved.)
- Published
- 2013
- Full Text
- View/download PDF
28. Practice-based interventions addressing concomitant depression and chronic medical conditions in the primary care setting: a systematic review and meta-analysis.
- Author
-
Watson LC, Amick HR, Gaynes BN, Brownley KA, Thaker S, Viswanathan M, and Jonas DE
- Subjects
- Arthritis therapy, Depression complications, Depressive Disorder complications, Diabetes Mellitus therapy, HIV Infections therapy, Heart Diseases therapy, Humans, Neoplasms therapy, Chronic Disease therapy, Cooperative Behavior, Delivery of Health Care, Depression therapy, Depressive Disorder therapy, Primary Health Care
- Abstract
Background: Depression concomitant with chronic medical conditions is common and burdensome in primary care., Objective: To assess the effectiveness of practice-based interventions for improving depression and chronic medical outcomes., Data Sources: MEDLINE, Embase, the Cochrane Library, CINAHL, and PsycINFO from inception to June 11, 2012., Study Selection, Appraisal, and Synthesis: Two reviewers independently selected, extracted data from, and rated the quality of trials and systematic reviews. Strength of evidence (SOE) was graded using established criteria., Results: Twenty-four published articles reported data from 12 studies, all at least 6 months long. All studies compared a form of collaborative care with usual or enhanced usual care. Studies evaluated adults with arthritis, cancer, diabetes, heart disease, HIV, or multiple medical conditions. Meta-analyses found that intervention recipients achieved greater improvement than controls in depression symptoms, response, remission, and depression-free days (moderate SOE); satisfaction with care (moderate SOE); and quality of life (moderate SOE). Few data were available on outcomes for chronic medical conditions. Meta-analyses revealed that patients with diabetes receiving collaborative care exhibited no difference in diabetes control compared with control groups (change in HbA1c: weighted mean difference 0.13, 95% confidence interval = -0.22 to 0.48 at 6 months; 0.24, 95% confidence interval = -0.14 to 0.62 at 12 months; low SOE). The only study to use HbA1c as a predefined outcome measure and a "treat-to-target" intervention for diabetes as well as depression, TEAMcare, reported significant reductions in HbA1c (7.42 vs 7.87 at 6 months; 7.33 vs 7.81 at 12 months; overall P < .001)., Limitations: Few relevant trials reported on medical outcomes., Conclusions: Collaborative care interventions improved outcomes for depression and quality of life in primary care patients with varying medical conditions. Few data were available on medical outcomes. Future studies of concomitant depression and chronic medical conditions should consider measures of medical outcomes as primary outcomes.
- Published
- 2013
- Full Text
- View/download PDF
29. A double-blind, randomized pilot trial of chromium picolinate for binge eating disorder: results of the Binge Eating and Chromium (BEACh) study.
- Author
-
Brownley KA, Von Holle A, Hamer RM, La Via M, and Bulik CM
- Subjects
- Adult, Body Mass Index, Body Weight drug effects, Double-Blind Method, Female, Humans, Iron Chelating Agents administration & dosage, Male, Middle Aged, Picolinic Acids administration & dosage, Treatment Outcome, Binge-Eating Disorder drug therapy, Iron Chelating Agents therapeutic use, Overweight drug therapy, Picolinic Acids therapeutic use
- Abstract
Objective: Chromium treatment has been shown to improve mood, appetite, and glucose regulation in various psychiatric and medical patient populations. The authors propose that chromium may be useful in the treatment of binge eating disorder (BED)., Method: Twenty-four overweight adults with BED were enrolled in a 6-month double-blind placebo-controlled trial and randomly assigned to receive either 1000mcg chromium/day ("high dose"; n=8) or 600mcg chromium/day ("moderate dose"; n=9) as chromium picolinate or placebo (n=7). Mixed linear regression models were used to estimate mean change in binge frequency and related psychopathology, weight, symptoms of depression, and fasting glucose., Results: Fasting glucose was significantly reduced in both chromium groups compared to the placebo group; similarly, numerically, but not significantly, greater reductions in binge frequency, weight, and symptoms of depression were observed in those treated with chromium versus placebo, although statistical power was limited in this pilot trial. For fasting glucose, the findings suggest a dose response with larger effects in the high dose compared to moderate dose group., Conclusion: These initial findings support further larger trials to determine chromium's efficacy in maintaining normal glucose regulation, reducing binge eating and related psychopathology, promoting modest weight loss, and reducing symptoms of depression in individuals with BED. Studies designed to link the clinical effects of chromium with changes in underlying insulin, serotonin, and dopamine pathways may be especially informative. If efficacious, chromium supplementation may provide a useful, low-cost alternative to or augmentation strategy for selective serotonin reuptake inhibitors, which have partial efficacy in BED. ClinicalTrials.gov NCT00904306., (Copyright © 2013 Elsevier Inc. All rights reserved.)
- Published
- 2013
- Full Text
- View/download PDF
30. Interventions to prevent post-traumatic stress disorder: a systematic review.
- Author
-
Forneris CA, Gartlehner G, Brownley KA, Gaynes BN, Sonis J, Coker-Schwimmer E, Jonas DE, Greenblatt A, Wilkins TM, Woodell CL, and Lohr KN
- Subjects
- Adolescent, Adult, Aged, Female, Humans, Male, Middle Aged, Primary Prevention, Young Adult, Stress Disorders, Post-Traumatic prevention & control
- Abstract
Context: Traumatic events are prevalent worldwide; trauma victims seek help in numerous clinical and emergency settings. Using effective interventions to prevent post-traumatic stress disorder (PTSD) is increasingly important. This review assessed the efficacy, comparative effectiveness, and harms of psychological, pharmacologic, and emerging interventions to prevent PTSD., Evidence Acquisition: The following sources were searched for research on interventions to be included in the review: MEDLINE; Cochrane Library; CINAHL; EMBASE; PILOTS (Published International Literature on Traumatic Stress); International Pharmaceutical Abstracts; PsycINFO; Web of Science; reference lists of published literature; and unpublished literature (January 1, 1980 to July 30, 2012). Two reviewers independently selected studies, extracted data or checked accuracy, assessed study risk of bias, and graded strength of evidence. All data synthesis occurred between January and September 2012., Evidence Synthesis: Nineteen studies covered various populations, traumas, and interventions. In meta-analyses of three trials (from the same team) for people with acute stress disorder, brief trauma-focused cognitive behavioral therapy was more effective than supportive counseling in reducing the severity of PTSD symptoms (moderate-strength); these two interventions had similar results for incidence of PTSD (low-strength); depression severity (low-strength); and anxiety severity (moderate-strength). PTSD symptom severity after injury decreased more with collaborative care than usual care (single study; low-strength). Debriefing did not reduce incidence or severity of PTSD or psychological symptoms in civilian traumas (low-strength). Evidence about relevant outcomes was unavailable for many interventions or was insufficient owing to methodologic shortcomings., Conclusions: Evidence is very limited regarding best practices to treat trauma-exposed individuals. Brief cognitive behavioral therapy may reduce PTSD symptom severity in people with acute stress disorder; collaborative care may help decrease symptom severity post-injury., (Copyright © 2013 American Journal of Preventive Medicine. Published by Elsevier Inc. All rights reserved.)
- Published
- 2013
- Full Text
- View/download PDF
31. Characteristics of women with body size satisfaction at midlife: results of the Gender and Body Image (GABI) Study.
- Author
-
Runfola CD, Von Holle A, Peat CM, Gagne DA, Brownley KA, Hofmeier SM, and Bulik CM
- Subjects
- Aged, Body Mass Index, Body Weight, Diet, Reducing, Exercise, Feeding and Eating Disorders psychology, Female, Humans, Middle Aged, Body Image psychology, Personal Satisfaction
- Abstract
This study characterizes the profile of women (N = 1,789) ages 50 and over who report body size satisfaction on a figure rating scale. Satisfied women (12.2%) had a lower body mass index and reported fewer eating disorder symptoms, dieting behaviors, and weight and appearance dissatisfaction. Interestingly, satisfied women exercised more than dissatisfied women, and weight and shape still played a primary role in their self-evaluation. Weight monitoring and appearance-altering behaviors did not differ between groups. Body satisfaction was associated with better overall functioning. This end point appears to represent effortful body satisfaction rather than passive contentment.
- Published
- 2013
- Full Text
- View/download PDF
32. Body dissatisfaction in women across the lifespan: results of the UNC-SELF and Gender and Body Image (GABI) studies.
- Author
-
Runfola CD, Von Holle A, Trace SE, Brownley KA, Hofmeier SM, Gagne DA, and Bulik CM
- Subjects
- Adult, Age Factors, Aged, Aged, 80 and over, Body Mass Index, Cross-Sectional Studies, Female, Humans, Middle Aged, Overweight psychology, Body Image psychology, Personal Satisfaction, Women psychology
- Abstract
To explore age differences in current and preferred silhouette and body dissatisfaction (current - preferred silhouette discrepancy) in women aged 25-89 years using figural stimuli [range: 1 (very small) to 9 (very large)]. Data were abstracted from two online convenience samples (N = 5868). t-tests with permutation-adjusted p-values examined linear associations between mean silhouette scores (current, preferred, discrepancy score) and age with/without stratification by body mass index (BMI). Modal current silhouette was 5; modal preferred silhouette was 4; mean discrepancy score was 1.8. There was no significant association between current silhouette and age, but a positive linear association between preferred silhouette and age remained after stratification by BMI. A significant inverse linear association of silhouette discrepancy score and age was found only prior to stratification by BMI. Body dissatisfaction exists in women across the adult life span and is influenced by BMI., (Copyright © 2012 John Wiley & Sons, Ltd and Eating Disorders Association.)
- Published
- 2013
- Full Text
- View/download PDF
33. Behavioral counseling after screening for alcohol misuse in primary care: a systematic review and meta-analysis for the U.S. Preventive Services Task Force.
- Author
-
Jonas DE, Garbutt JC, Amick HR, Brown JM, Brownley KA, Council CL, Viera AJ, Wilkins TM, Schwartz CJ, Richmond EM, Yeatts J, Evans TS, Wood SD, and Harris RP
- Subjects
- Alcohol Drinking, Alcohol-Related Disorders complications, Humans, Randomized Controlled Trials as Topic, Alcohol-Related Disorders therapy, Behavior Therapy methods, Counseling, Primary Health Care
- Abstract
Background: Alcohol misuse, which includes the full spectrum from risky drinking to alcohol dependence, is a leading cause of preventable death in the United States., Purpose: To evaluate the benefits and harms of behavioral counseling interventions for adolescents and adults who misuse alcohol., Data Sources: MEDLINE, EMBASE, the Cochrane Library, CINAHL, PsycINFO, International Pharmaceutical Abstracts, and reference lists of published literature (January 1985 through January 2012, limited to English-language articles)., Study Selection: Controlled trials at least 6 months' duration that enrolled persons with alcohol misuse identified by screening in primary care settings and evaluated behavioral counseling interventions., Data Extraction: One reviewer extracted data and a second checked accuracy. Two independent reviewers assigned quality ratings and graded the strength of the evidence., Data Synthesis: The 23 included trials generally excluded persons with alcohol dependence. The best evidence was for brief (10- to 15-minute) multicontact interventions. Among adults receiving behavioral interventions, consumption decreased by 3.6 drinks per week from baseline (weighted mean difference, 3.6 drinks/wk [95% CI, 2.4 to 4.8 drinks/wk]; 10 trials; 4332 participants), 12% fewer adults reported heavy drinking episodes (risk difference, 0.12 [CI, 0.07 to 0.16]; 7 trials; 2737 participants), and 11% more adults reported drinking less than the recommended limits (risk difference, 0.11 [CI, 0.08 to 0.13]; 9 trials; 5973 participants) over 12 months compared with control participants (moderate strength of evidence). Evidence was insufficient to draw conclusions about accidents, injuries, or alcohol-related liver problems. Trials enrolling young adults or college students showed reduced consumption and fewer heavy drinking episodes (moderate strength of evidence). Little or no evidence of harms was found., Limitations: Results may be biased to the null because the behavior of control participants could have been affected by alcohol misuse assessments. In addition, evidence is probably inapplicable to persons with alcohol dependence and selective reporting may have occurred., Conclusion: Behavioral counseling interventions improve behavioral outcomes for adults with risky drinking., Primary Funding Source: Agency for Healthcare Research and Quality.
- Published
- 2012
- Full Text
- View/download PDF
34. Eating disorder symptoms and weight and shape concerns in a large web-based convenience sample of women ages 50 and above: results of the Gender and Body Image (GABI) study.
- Author
-
Gagne DA, Von Holle A, Brownley KA, Runfola CD, Hofmeier S, Branch KE, and Bulik CM
- Subjects
- Age Factors, Aged, Body Mass Index, Diet, Reducing, Feeding and Eating Disorders psychology, Female, Health Surveys, Humans, Internet, Middle Aged, Surveys and Questionnaires, Body Image, Body Weight, Feeding Behavior psychology, Feeding and Eating Disorders diagnosis, Self Concept
- Abstract
Objective: Limited research exists on eating disorder symptoms and attitudes and weight and shape concerns in women in midlife to older adulthood. We conducted an online survey to characterize these behaviors and concerns in women ages 50 and above., Method: Participants (n = 1,849) were recruited via the Internet and convenience sampling., Results: Eating disorder symptoms, dieting and body checking behaviors, and weight and shape concerns were widely endorsed. Younger age and higher body mass index (BMI) were associated with greater endorsement of eating disorder symptoms, behaviors, and concerns., Discussion: Weight and shape concerns and disordered eating behaviors occur in women over 50 and vary by age and BMI. Focused research on disordered eating patterns in this age group is necessary to develop age-appropriate interventions and to meet the developmental needs of an important, growing, and underserved population., (Copyright © 2012 Wiley Periodicals, Inc.)
- Published
- 2012
- Full Text
- View/download PDF
35. Evaluation of gastric fundus invagination for weight loss in a porcine model.
- Author
-
Darido E, Overby DW, Brownley KA, and Farrell TM
- Subjects
- Animals, Body Weight, Disease Models, Animal, Eating, Female, Random Allocation, Swine growth & development, Fundoplication methods, Gastric Fundus surgery, Obesity surgery, Weight Loss
- Abstract
Gastric fundus compliance allows stomach volume increase in response to food intake. Absence of this postprandial relaxation alters hormonal signals and induces early satiety and weight loss. This study demonstrates the effect of gastric fundus invagination on the growth rate of juvenile pigs. After institutional animal care and use committee approval, 15 juvenile pigs were divided into two groups. In the first group, six pigs were anesthetized, weighed, and submitted to laparotomy, stomach manipulation, and short gastric vessel ligation. This is the control group and is referred to as "Sham". In the second group, gastric fundus invagination was added by using a circular stapler. This is the procedure group and is designated as "GFI". Postoperatively, body weight and food intake were measured for 5 weeks. Pigs were euthanized and the stomachs examined. Growth patterns were compared. Three animals were excluded from the analysis. At the end of the 5-week study period, six GFI pigs had intact anastomosis with an invaginated fundus. The mean percent growth rate for the GFI group (54.2 ± 2.8 %) was significantly less than the Sham group (77.7 ± 4.9 %). Gastric fundus invagination significantly decreases the growth rate in juvenile pigs.
- Published
- 2012
- Full Text
- View/download PDF
36. Plasma, salivary, and urinary oxytocin in anorexia nervosa: a pilot study.
- Author
-
Hoffman ER, Brownley KA, Hamer RM, and Bulik CM
- Subjects
- Adolescent, Adult, Anorexia Nervosa blood, Anorexia Nervosa urine, Female, Humans, Oxytocin blood, Oxytocin urine, Pilot Projects, Saliva metabolism, Anorexia Nervosa metabolism, Oxytocin metabolism
- Abstract
Although oxytocin (OT) has the potential to be an informative biomarker of social functioning in patients with eating disorders, the burden of invasive blood draws or lumbar punctures limits OT study. Salivary and urinary OT measurements may be advantageous, as they require less invasive sampling techniques which could be conducted in a wider variety of settings. Yet, the degree to which the concentration of OT in these fluids is correlated with blood levels is uncertain, as is the impact of vomiting on salivary secretion of OT. Therefore, we compared contemporaneously sampled OT concentration in blood, saliva, and urine from twenty women acutely ill with anorexia nervosa. Salivary OT was positively correlated with plasma OT in patients with no history of self-induced vomiting (r=0.89), but correlation was lower in those with recent history of self-induced vomiting (r=0.42). Urinary and plasma OT were not well-correlated(r=0.13), suggesting preliminarily that collection of plasma OT remains the method of choice. Self-induced vomiting in eating disorders may limit the applicability of salivary sampling for OT., (Copyright © 2012 Elsevier Ltd. All rights reserved.)
- Published
- 2012
- Full Text
- View/download PDF
37. Low-glycemic load decreases postprandial insulin and glucose and increases postprandial ghrelin in white but not black women.
- Author
-
Brownley KA, Heymen S, Hinderliter AL, Galanko J, and Macintosh B
- Subjects
- Adult, Body Mass Index, Diet, Dietary Carbohydrates blood, Female, Humans, Obesity blood, Postprandial Period, Young Adult, Black People, Blood Glucose metabolism, Ghrelin blood, Glycemic Index ethnology, Insulin blood, Obesity ethnology, White People
- Abstract
Alterations in appetite hormones favoring increased postprandial satiety have been implicated in both the glycemic control and potential weight-loss benefits of a low-glycemic diet. Racial differences exist in dietary glycemic load and appetite hormone concentrations. This study examined the impact of glycemic load on appetite hormones in 20 black women [10 normal weight, BMI = 22.8 ± 1.42 (mean ± SD); 10 obese, BMI = 35.1 ± 2.77] and 20 white women (10 normal weight, BMI = 22.9 ± 1.45; 10 obese, BMI = 34.3 ± 2.77). Each woman completed two 4.5-d weight-maintenance, mixed-macronutrient, high-glycemic vs. low-glycemic load diets that concluded with a test meal of identical composition. Blood samples collected before and serially for 3 h after each test meal were assayed for plasma ghrelin and serum insulin and glucose concentrations. Compared with the high-glycemic load meal, the low-glycemic load meal was associated with lower insulin(AUC) (P = 0.02), glucose(AUC) (P = 0.01), and urge to eat ratings (P = 0.05) but with higher ghrelin(AUC) (P = 0.008). These results suggest the satiating effect of a low-glycemic load meal is not directly linked to enhanced postprandial suppression of ghrelin. Notably, these effects were significant among white but not black women, suggesting that black women may be less sensitive than white women to the glucoregulatory effects of a low-glycemic load. These findings add to a growing literature demonstrating racial differences in postprandial appetite hormone responses. If reproducible, these findings have implications for individualized diet prescription for the purposes of glucose or weight control in women.
- Published
- 2012
- Full Text
- View/download PDF
38. Binge eating disorder: Evidence-based treatments.
- Author
-
Peat CM, Brownley KA, Berkman ND, and Bulik CM
- Published
- 2012
39. Effect of glycemic load on peptide-YY levels in a biracial sample of obese and normal weight women.
- Author
-
Brownley KA, Heymen S, Hinderliter AL, and MacIntosh B
- Subjects
- Adult, Eating physiology, Fasting physiology, Female, Humans, Insulin Resistance physiology, Prevalence, United States epidemiology, White People statistics & numerical data, Young Adult, Black or African American, Black People statistics & numerical data, Body Weight physiology, Hyperglycemia ethnology, Hyperglycemia metabolism, Obesity ethnology, Obesity metabolism, Peptide YY blood
- Abstract
Black women suffer a disproportionately higher rate of obesity than their white counterparts. Reasons for this racial disparity may reflect underlying differences in the appetite suppressing peptide-YY (PYY). The PYY response to food is differentially influenced by macronutrient content but the effect of glycemic load on PYY response is unknown. This study examined whether glycemic load influences fasting and postprandial PYY levels and whether fasting and postprandial PYY levels are lower in obese black women compared to normal weight black women and to white women. Data were collected from 40 women (20 black, 20 white; 10 each normal weight vs. obese) at the University of North Carolina Clinical and Translational Research Center (CTRC). Participants completed in counterbalanced order two 4(1/2)-day weight-maintenance, mixed macronutrient high vs. low glycemic load diets followed by a test meal of identical composition. Total PYY levels were assessed before and after each test meal. Results show no differences in fasting PYY levels but significantly less postprandial PYY area under the curve (PYY(AUC)) in the group of obese black women compared to each other group (race x obesity interaction, P < 0.04). PYY(AUC) was positively related to insulin sensitivity (P < 0.004) but was not affected by glycemic load (main and interactive effects, P > 0.27). These findings indicate that postprandial PYY secretion is not affected by glycemic load but is blunted in obese black women compared with normal weight black women and with white women; additionally, they begin to address whether blunted PYY secretion contributes uniquely to the pathogenesis of obesity in black women.
- Published
- 2010
- Full Text
- View/download PDF
40. Malodor as a trigger of stress and negative mood in neighbors of industrial hog operations.
- Author
-
Horton RA, Wing S, Marshall SW, and Brownley KA
- Subjects
- Animals, Female, Housing, Animal, Humans, Longitudinal Studies, Male, Middle Aged, North Carolina, Air Pollutants adverse effects, Air Pollutants analysis, Industry, Negativism, Odorants, Stress, Psychological etiology, Swine
- Abstract
Objectives: We evaluated malodor and air pollutants near industrial hog operations as environmental stressors and negative mood triggers., Methods: We collected data from 101 nonsmoking adults in 16 neighborhoods within 1.5 miles of at least 1 industrial hog operation in eastern North Carolina. Participants rated malodor intensity, stress, and mood for 2 weeks while air pollutants were monitored., Results: Reported malodor was associated with stress and 4 mood states; odds ratios (ORs) for a 1-unit change on the 0-to-8 odor scale ranged from 1.31 (95% confidence interval [CI] = 1.16, 1.50) to 1.81 (95% CI = 1.63, 2.00). ORs for stress and feeling nervous or anxious were 1.18 (95% CI = 1.08, 1.30) and 1.12 (95% CI = 1.03, 1.22), respectively, for a 1 ppb change in hydrogen sulfide and 1.06 (95% CI = 1.00, 1.11) and 1.10 (95% CI = 1.03, 1.17), respectively, for a 1 microg/m(3) change in semivolatile particulate matter less than 10 microm in aerodynamic diameter (PM(10))., Conclusions: Hog odor, hydrogen sulfide, and semivolatile PM(10) are related to stress and negative mood in disproportionately low-income communities near industrial hog operations in eastern North Carolina. Malodor should be considered in studies of health impacts of environmental injustice.
- Published
- 2009
- Full Text
- View/download PDF
41. The biology of binge eating.
- Author
-
Mathes WF, Brownley KA, Mo X, and Bulik CM
- Subjects
- Analgesics, Opioid metabolism, Animals, Behavior, Addictive, Bulimia genetics, Bulimia metabolism, Bulimia psychology, Bulimia Nervosa genetics, Bulimia Nervosa metabolism, Bulimia Nervosa psychology, Disease Models, Animal, Dopamine metabolism, Food Deprivation, Food Preferences psychology, Humans, Hyperphagia physiopathology, Taste, Bulimia etiology, Bulimia Nervosa etiology, Environment, Stress, Psychological complications
- Abstract
Objective: To examine the literature on binge eating to gain a better understanding of its biological foundations and their role in eating disorders., Method: Literature review and synthesis., Results: Research using animal models has revealed several factors that contribute to the development and maintenance of binge eating. These factors, including stress, food restriction, the presence of palatable foods, and environmental conditioning, parallel many of the precursory circumstances leading to binge eating in individuals with bulimia nervosa and binge eating disorder., Discussion: The animal literature has opened a new avenue to aid in the understanding of the neurobiological basis of binge eating. Future endeavors examining the genetic and environmental correlates of binge eating behavior will further contribute to the understanding of the biological foundations of binge eating and assist with establishing diagnostic criteria and the development of novel treatments for eating disorders marked by binge eating.
- Published
- 2009
- Full Text
- View/download PDF
42. Adrenergic dysregulation and pain with and without acute beta-blockade in women with fibromyalgia and temporomandibular disorder.
- Author
-
Light KC, Bragdon EE, Grewen KM, Brownley KA, Girdler SS, and Maixner W
- Subjects
- Adult, Cross-Over Studies, Double-Blind Method, Epinephrine blood, Female, Fibromyalgia drug therapy, Hemodynamics physiology, Humans, Hydrocortisone blood, Middle Aged, Norepinephrine blood, Pain drug therapy, Pain etiology, Pain Measurement, Posture physiology, Propranolol therapeutic use, Stress, Psychological physiopathology, Stress, Psychological psychology, Temporomandibular Joint Disorders drug therapy, Adrenergic beta-Antagonists therapeutic use, Fibromyalgia physiopathology, Pain physiopathology, Sympathetic Nervous System physiopathology, Temporomandibular Joint Disorders physiopathology
- Abstract
Unlabelled: In patients with fibromyalgia syndrome (FMS) and temporomandibular disorder (TMD), stress and pain may chronically enhance sympathetic activity, altering cardiovascular responses and worsening pain. This study examined cardiovascular, epinephrine (EPI), norepinephrine (NE), cortisol and clinical pain responses in 54 female patients with these disorders and 34 controls. In a subsample of 10 FMS, 10 TMD patients and 16 controls, using a counterbalanced, double-blind, crossover design, the same responses were assessed after intravenous administration of low dose propranolol vs placebo. Testing included baseline, postural, speech and ischemic pain stressors. FMS patients showed lesser heart rate (HR) increases to posture challenge but greater blood pressure (BP) increases to postural and speech tasks than controls, as well as higher overall BP and greater total vascular resistance (TVR) than TMDs or controls. TMDs showed higher overall cardiac output and lower TVR than controls. Both FMS and TMD groups showed lower baseline NE than controls, and TMDs showed lower overall EPI and NE levels. Group differences in HR, EPI and NE were abolished after propranolol although BP, CO and TVR differences persisted. In both FMS and TMD, the number of painful body sites and ratings of total clinical pain obtained 4 times during each session were significantly lower after beta-blockade vs placebo., Perspective: These findings support the hypothesis that both FMS and TMD may frequently involve dysregulation of beta-adrenergic activity that contributes to altered cardiovascular and catecholamine responses and to severity of clinical pain. Acute treatment with low-dose propranolol led to short-term improvement in all these domains.
- Published
- 2009
- Full Text
- View/download PDF
43. Early treatment-related changes in diabetes and cardiovascular disease risk markers in first episode psychosis subjects.
- Author
-
Graham KA, Cho H, Brownley KA, and Harp JB
- Subjects
- Adolescent, Adult, Blood Glucose drug effects, Body Mass Index, Cholesterol, HDL blood, Cholesterol, LDL blood, Female, Follow-Up Studies, Humans, Insulin blood, Leptin blood, Male, Psychotic Disorders blood, Psychotic Disorders drug therapy, Retrospective Studies, Risk Factors, Statistics, Nonparametric, Triglycerides metabolism, Antipsychotic Agents adverse effects, Cardiovascular Diseases chemically induced, Cardiovascular Diseases diagnosis, Diabetes Mellitus chemically induced, Diabetes Mellitus diagnosis
- Abstract
Objective: To examine prospective changes in cardiovascular disease (CVD) and type-2 diabetes risk factors in young adult first episode psychotic (FEP) patients treated with second generation antipsychotic medications., Methods: At baseline, fasting serum and anthropometric measures were obtained from 45 FEP patients and 41 healthy adults (controls) of similar age, ethnicity and sex; sixteen of the FEP patients remained on the same antipsychotic medication and were available for a second blood draw at 24 weeks of treatment. Serum was assayed for glucose, insulin, triglycerides, total cholesterol and high and low density lipoproteins (HDL, LDL), adiponectin, leptin, interleukin 6, E-selectin and VCAM-1. Wilcoxon nonparametric tests were used to compare risk markers between the FEP and control group at baseline and to evaluate pre-post treatment changes within the FEP group., Results: At baseline, the distributions of risk marker values were similar between the two groups and the percentages of FEP patients and healthy controls who were overweight/obese, dyslipidemic, hyperglycemic, and hyperinsulinemic did not differ. At 24 weeks, compared to baseline, FEP patients showed significant increases in BMI (p=0.0002), glucose (p=0.0449), insulin (p=0.0161), cholesterol (p=0.0129), leptin (p=0.0215), and E-selectin (p=0.0195), and a decrease in adiponectin (p=0.0371)., Conclusions: Among patients with first episode psychosis, 6-month treatment with second generation antipsychotics is associated with the exacerbation of pre-existing and emergence of new CVD and diabetes risk factors.
- Published
- 2008
- Full Text
- View/download PDF
44. Diagnosis and management of binge eating disorder.
- Author
-
Bulik CM, Brownley KA, and Shapiro JR
- Abstract
This paper addresses current issues regarding the diagnosis and management of binge eating disorder (BED). Controversies in diagnosis include the lack of empirically validated criteria, the lack of a universally recognized operational definition of a "binge episode", and the lack of age-appropriate assessment instruments in light of growing reports of BED among children and adolescents. For adults with BED, several pharmacological and behavioral treatments have shown promise in reducing binge frequency and related psychological symptoms of disordered eating (i.e., disinhibition, hunger, depressed mood). Second-generation antidepressants and cognitive behavioral therapy are among the most widely studied treatments. However, no behavioral interventions have demonstrated efficacy with respect to weight loss (which is a critical concern for many BED sufferers who are overweight). Furthermore, randomized controlled trials for BED have been plagued by high drop out and placebo response rates, as well as by insufficient follow-up after active treatment ends to determine long-term outcomes. Therefore, the long-term utility of the various intervention strategies studied thus far remains unclear. More research is needed on innovative medications and behavioral treatments that explore novel modalities to reduce the subjectively reinforcing properties of binge eating. In addition, expanded use of information technologies may be particularly instrumental in the treatment of patients who experience marked shame, denial, and interpersonal deficits, or who face limited access to specialty care. Ultimately, examining BED within the broader context of the current obesity epidemic will be an important area of study.
- Published
- 2007
45. Binge eating disorder treatment: a systematic review of randomized controlled trials.
- Author
-
Brownley KA, Berkman ND, Sedway JA, Lohr KN, and Bulik CM
- Subjects
- Bulimia Nervosa diagnosis, Humans, Randomized Controlled Trials as Topic, Behavior Therapy methods, Bulimia Nervosa psychology, Bulimia Nervosa therapy
- Abstract
Objective: The Research Triangle Institute-University of North Carolina Evidence Based Practice Center (RTI-EPC) systematically reviewed evidence on efficacy of treatment for binge eating disorder (BED), harms associated with treatments, factors associated with treatment efficacy, and differential outcome by sociodemographic characteristics., Method: We searched six major databases for studies on the treatment of BED published from 1980 to September, 2005, in all languages against a priori inclusion/exclusion criteria and focused on eating, psychiatric or psychological, or biomarker outcomes., Results: Twenty-six studies, including medication-only, medication plus behavioral intervention, and behavioral intervention only designs, met inclusion criteria. The strength of the evidence for medication and behavioral interventions was moderate, for self-help and other interventions was weak, for treatment-related harms was strong, for factors associated with efficacy of treatment was weak, and for differential outcome by sociodemographic factors was nonexistent. Individual or group CBT reduces binge eating and improves abstinence rates for up to 4 months after treatment but does not lead to weight loss. Medications may play a role in treating BED patients., Conclusion: The literature regarding treatment efficacy for BED is variable. Future directions include the identification of optimal interventions that are associated with both sustained abstinence from binge eating and permanent weight loss.
- Published
- 2007
- Full Text
- View/download PDF
46. Anorexia nervosa treatment: a systematic review of randomized controlled trials.
- Author
-
Bulik CM, Berkman ND, Brownley KA, Sedway JA, and Lohr KN
- Subjects
- Humans, Randomized Controlled Trials as Topic, Anorexia Nervosa therapy
- Abstract
Objective: The RTI International-University of North Carolina at Chapel Hill Evidence-based Practice Center (RTI-UNC EPC) systematically reviewed evidence on efficacy of treatment for anorexia nervosa (AN), harms associated with treatments, factors associated with treatment efficacy, and differential outcome by sociodemographic characteristics., Method: We searched six major databases for studies on the treatment of AN from 1980 to September 2005, in all languages against a priori inclusion/exclusion criteria focusing on eating, psychiatric or psychological, or biomarker outcomes., Results: Thirty-two treatment studies involved only medications, only behavioral interventions, and medication plus behavioral interventions for adults or adolescents. The literature on medication treatments and behavioral treatments for adults with AN is sparse and inconclusive. Cognitive behavioral therapy may reduce relapse risk for adults with AN after weight restoration, although its efficacy in the underweight state remains unknown. Variants of family therapy are efficacious in adolescents, but not in adults., Conclusion: Evidence for AN treatment is weak; evidence for treatment-related harms and factors associated with efficacy of treatment are weak; and evidence for differential outcome by sociodemographic factors is nonexistent. Attention to sample size and statistical power, standardization of outcome measures, retention of patients in clinical trials, and developmental differences in treatment appropriateness and outcome is required.
- Published
- 2007
- Full Text
- View/download PDF
47. Bulimia nervosa treatment: a systematic review of randomized controlled trials.
- Author
-
Shapiro JR, Berkman ND, Brownley KA, Sedway JA, Lohr KN, and Bulik CM
- Subjects
- Humans, Randomized Controlled Trials as Topic, Bulimia Nervosa therapy
- Abstract
Objective: The RTI International-University of North Carolina at Chapel Hill Evidence-based Practice Center systematically reviewed evidence on efficacy of treatment for bulimia nervosa (BN), harms associated with treatments, factors associated with treatment efficacy, and differential outcome by sociodemographic characteristics., Method: We searched six major databases published from 1980 to September 2005 in all languages against a priori inclusion/exclusion criteria; we focused on eating, psychiatric or psychological, and biomarker outcomes., Results: Forty-seven studies of medication only, behavioral interventions only, and medication plus behavioral interventions for adults or adolescents met our inclusion criteria. Fluoxetine (60 mg/day) decreases the core symptoms of binge eating and purging and associated psychological features in the short term. Cognitive behavioral therapy reduces core behavioral and psychological features in the short and long term., Conclusion: Evidence for medication or behavioral treatment for BN is strong, for self-help is weak; for harms related to medication is strong but either weak or nonexistent for other interventions; and evidence for differential outcome by sociodemographic factors is nonexistent. Attention to sample size, standardization of outcome measures, attrition, and reporting of abstinence from target behaviors are required. Longer follow-up intervals, innovative treatments, and attention to sociodemographic factors would enhance the literature.
- Published
- 2007
- Full Text
- View/download PDF
48. Dietary sodium restriction alters postprandial ghrelin: implications for race differences in obesity.
- Author
-
Brownley KA, Light KC, Grewen KM, Hinderliter AL, and West SG
- Subjects
- Adult, Appetite drug effects, Biological Assay, Biomarkers blood, Blood Pressure drug effects, Body Mass Index, Cardiac Output drug effects, Female, Ghrelin, Heart Rate drug effects, Humans, Leptin blood, Male, Middle Aged, Norepinephrine blood, Obesity blood, Obesity physiopathology, Peptide Hormones drug effects, Plasma Volume drug effects, Research Design, Rest, Sex Factors, Vascular Resistance drug effects, Black People statistics & numerical data, Diet, Sodium-Restricted ethnology, Obesity diet therapy, Obesity ethnology, Peptide Hormones blood, Postprandial Period drug effects, White People statistics & numerical data
- Abstract
Objectives: To examine the effect of sodium restriction on the appetite-stimulating hormone, ghrelin, as a function of race, salt sensitivity, and obesity., Design: PARTICIPANTS completed two 4-day outpatient dietary interventions (moderate vs low sodium), and blood samples were drawn two hours after a controlled test meal under both conditions., Setting: A university research laboratory and affiliated General Clinical Research Center., Participants: 37 women (18 Black, 19 White) and 18 men (9 Black, 9 White), aged 36-63 years., Measures: Cardiovascular function (blood pressure, heart rate, impedance-derived indices of cardiac output and peripheral resistance) was measured after a 20-minute rest before each test meal. Blood was drawn by intravenous forearm catheter two hours after each test meal and later assayed for ghrelin, leptin, and norepinephrine., Results: After four days of sodium restriction, postprandial ghrelin increased in White men and women and Black men but decreased in Black women. Salt sensitivity, but not obesity, was also related to ghrelin response during sodium restriction; postprandial ghrelin tended to increase among salt-sensitive subjects during salt restriction but decrease among salt-resistant subjects during salt restriction., Conclusions: Satiety hormone dysregulation may play a role in: 1) the heightened obesity-related morbidity among Black women, in particular; 2) adherence to sodium-restricted diets; and 3) race differences in behavioral weight-loss interventions that include sodium restriction.
- Published
- 2006
49. Management of eating disorders.
- Author
-
Berkman ND, Bulik CM, Brownley KA, Lohr KN, Sedway JA, Rooks A, and Gartlehner G
- Subjects
- Adolescent, Adult, Anorexia Nervosa therapy, Antidepressive Agents therapeutic use, Bulimia Nervosa therapy, Combined Modality Therapy, Feeding and Eating Disorders drug therapy, Female, Humans, Male, Psychotherapy, Treatment Outcome, Feeding and Eating Disorders therapy
- Abstract
Objectives: The RTI International-University of North Carolina at Chapel Hill Evidence-based Practice Center (RTI-UNC EPC) systematically reviewed evidence on efficacy of treatment for anorexia nervosa (AN), bulimia nervosa (BN), and binge eating disorder (BED), harms associated with treatments, factors associated with the treatment efficacy and with outcomes of these conditions, and whether treatment and outcomes for these conditions differ by sociodemographic characteristics., Data Sources: We searched MEDLINE, the Cumulative Index to Nursing and Applied Health (CINAHL), PSYCHINFO, the Educational Resources Information Center (ERIC), the National Agricultural Library (AGRICOLA), and Cochrane Collaboration libraries., Review Methods: We reviewed each study against a priori inclusion/exclusion criteria. For included articles, a primary reviewer abstracted data directly into evidence tables; a second senior reviewer confirmed accuracy. We included studies published from 1980 to September 2005, in all languages. Studies had to involve populations diagnosed primarily with AN, BN, or BED and report on eating, psychiatric or psychological, or biomarker outcomes., Results: We report on 30 treatment studies for AN, 47 for BN, 25 for BED, and 34 outcome studies for AN, 13 for BN, 7 addressing both AN and BN, and 3 for BED. The AN literature on medications was sparse and inconclusive. Some forms of family therapy are efficacious in treating adolescents. Cognitive behavioral therapy (CBT) may reduce relapse risk for adults after weight restoration. For BN, fluoxetine (60 mg/day) reduces core bulimic symptoms (binge eating and purging) and associated psychological features in the short term. Individual or group CBT decreases core behavioral symptoms and psychological features in both the short and long term. How best to treat individuals who do not respond to CBT or fluoxetine remains unknown. In BED, individual or group CBT reduces binge eating and improves abstinence rates for up to 4 months after treatment; however, CBT is not associated with weight loss. Medications may play a role in treating BED patients. Further research addressing how best to achieve both abstinence from binge eating and weight loss in overweight patients is needed. Higher levels of depression and compulsivity were associated with poorer outcomes in AN; higher mortality was associated with concurrent alcohol and substance use disorders. Only depression was consistently associated with poorer outcomes in BN; BN was not associated with an increased risk of death. Because of sparse data, we could reach no conclusions concerning BED outcomes. No or only weak evidence addresses treatment or outcomes difference for these disorders., Conclusions: The literature regarding treatment efficacy and outcomes for AN, BN, and BED is of highly variable quality. In future studies, researchers must attend to issues of statistical power, research design, standardized outcome measures, and sophistication and appropriateness of statistical methodology.
- Published
- 2006
50. Oxytocinergic activity is linked to lower blood pressure and vascular resistance during stress in postmenopausal women on estrogen replacement.
- Author
-
Light KC, Grewen KM, Amico JA, Brownley KA, West SG, Hinderliter AL, and Girdler SS
- Subjects
- Adult, Aged, Analysis of Variance, Blood Pressure drug effects, Drug Therapy, Combination, Estrogen Replacement Therapy, Estrogens pharmacology, Female, Humans, Hypothalamus metabolism, Medroxyprogesterone Acetate pharmacology, Middle Aged, Oxytocin analogs & derivatives, Postmenopause drug effects, Protein Precursors, Blood Pressure physiology, Estrogens, Conjugated (USP) pharmacology, Oxytocin drug effects, Oxytocin metabolism, Postmenopause physiology, Stress, Psychological blood
- Abstract
Estrogen administration results in increased release of the oxytocin (OT) prohormone reflected by increases in oxytocin intermediate peptide (OT Int) in both animal models and humans, and sequential treatment of ovariectomized rats with estrogen/progesterone then progesterone withdrawal leads to increased hypothalamic OT mRNA. Blood pressure (BP) reductions have been related to increased exogenous and endogenous OT in rats and to higher endogenous OT activity in premenopausal women, but not previously in postmenopausal women. Thus, we used plasma obtained at rest and during a speech stressor from 54 postmenopausal women who participated in a 6-month randomized trial of oral conjugated estrogens vs. placebo to examine effects of estrogen replacement therapy (ERT) on plasma OT and OT Int levels and their relationships to changes in BP during the trial. ERT alone and with progesterone (but not placebo) led to significant increases in plasma levels of OT Int, but no change in plasma OT levels. Women showing greater increases in OT Int during treatment showed greater decreases in BP and total vascular resistance during a series of behavioral stressors compared to women with moderate or no increases in OT Int, even after controlling for effects related to treatment condition or to changes in plasma estradiol. The findings suggest that enhanced oxytocinergic activity may contribute to BP decreases associated with ERT in more responsive postmenopausal women.
- Published
- 2005
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.